Biomira's Phase 2 Lung Cancer Vaccine Trial Shows No Safety Concerns
20th Nov 2005, 19:59 GMT
Biomira Inc announced the interim results of a phase 2 non-small cell lung cancer (NSCLC) single-arm, multi-centre, open label study of BLP25 Liposome Vaccine (L-BLP25) showing that the new formulation of the vaccine is not different from the previous formulation from a safety perspective. The reformulated vaccine incorporated manufacturing changes intended to secure the future commercial supply of the vaccine... click link for more info.
Biomira's Phase 2 Lung Cancer Vaccine Trial Shows No Safety Concerns related news:
- Biomira's re-worked cancer vaccine looks as safe as ever — Pharmaceutical Business Review Online
- 1st Patient Enrolled in Investigator-Sponsored Phase 1/2 Trial of Antigenics' Oncophage Cancer Vaccine in Glioma — Neurology News from StratCenter.com
- Tobacco related lung cancer gets help from plant — The Cancer Blog
- Emergent's typhoid vaccine in phase 2 — United Press International - Health Business
- Lung cancer linked to missing protein — The Cancer Blog
- Scottish women, who have high incidence of cervical cancer, given vaccine — The Cancer Blog
- New Clues to Vitamin A Resistance in Lung Cancer Found — iVillage Health & Well-Being News
- Sunesis cancer drug shows promise — Pharmaceutical Business Review Online
- CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial — Information Technologies/ MIS/ HIS News from StratCenter.com
- Novel pancreatic cancer vaccine nudging survival rates higher — Medical News Today RSS/XML Feed
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes